403 related articles for article (PubMed ID: 20509889)
21. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
Yadav P; Ellinghaus D; Rémy G; Freitag-Wolf S; Cesaro A; Degenhardt F; Boucher G; Delacre M; ; Peyrin-Biroulet L; Pichavant M; Rioux JD; Gosset P; Franke A; Schumm LP; Krawczak M; Chamaillard M; Dempfle A; Andersen V
Gastroenterology; 2017 Aug; 153(2):550-565. PubMed ID: 28506689
[TBL] [Abstract][Full Text] [Related]
22. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease.
Bioque G; Crusius JB; Koutroubakis I; Bouma G; Kostense PJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1995 Nov; 102(2):379-83. PubMed ID: 7586694
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.
Andersen V; Nimmo E; Krarup HB; Drummond H; Christensen J; Ho GT; Ostergaard M; Ernst A; Lees C; Jacobsen BA; Satsangi J; Vogel U
Inflamm Bowel Dis; 2011 Apr; 17(4):937-46. PubMed ID: 20803508
[TBL] [Abstract][Full Text] [Related]
24. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of the cytokine genes TGFB1 and IL10 in a mixed-race population with Crohn's disease.
Almeida NP; Santana GO; Almeida TC; Bendicho MT; Lemaire DC; Cardeal M; Lyra AC
BMC Res Notes; 2013 Sep; 6():387. PubMed ID: 24074435
[TBL] [Abstract][Full Text] [Related]
26. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.
Rigoli L; Romano C; Caruso RA; Lo Presti MA; Di Bella C; Procopio V; Lo Giudice G; Amorini M; Costantino G; Sergi MD; Cuppari C; Calabro GE; Gallizzi R; Salpietro CD; Fries W
World J Gastroenterol; 2008 Jul; 14(28):4454-61. PubMed ID: 18680223
[TBL] [Abstract][Full Text] [Related]
28. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease.
López-Hernández R; Valdés M; Campillo JA; Martínez-García P; Salama H; Bolarin JM; Martínez H; Moya-Quiles MR; Minguela A; Sánchez-Torres A; Botella C; Salgado G; Miras M; Carballo F; Muro M
Int J Immunogenet; 2015 Feb; 42(1):38-45. PubMed ID: 25359546
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.
Li J; Tian H; Jiang HJ; Han B
World J Gastroenterol; 2014 Nov; 20(42):15899-909. PubMed ID: 25400476
[TBL] [Abstract][Full Text] [Related]
30. An Analysis of IL-10/IL-10R Genetic Factors Related to Risk of Colon Cancer and Inflammatory Bowel Disease in a Han Chinese Population.
Cai J; Zhang Z
Clin Lab; 2016; 62(6):1147-54. PubMed ID: 27468578
[TBL] [Abstract][Full Text] [Related]
31. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease.
Latiano A; Palmieri O; Pastorelli L; Vecchi M; Pizarro TT; Bossa F; Merla G; Augello B; Latiano T; Corritore G; Settesoldi A; Valvano MR; D'Incà R; Stronati L; Annese V; Andriulli A
PLoS One; 2013; 8(4):e62144. PubMed ID: 23634226
[TBL] [Abstract][Full Text] [Related]
32. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.
Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J
Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072
[TBL] [Abstract][Full Text] [Related]
33. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
34. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease.
Lv H; Jiang Y; Li J; Zhang M; Shang Z; Zheng J; Wu X; Liu P; Zhang R; Yu H
Mol Biol Rep; 2014 Mar; 41(3):1299-310. PubMed ID: 24407599
[TBL] [Abstract][Full Text] [Related]
35. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
36. Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population.
Pranculienė G; Steponaitienė R; Skiecevičienė J; Kučinskienė R; Kiudelis G; Adamonis K; Labanauskas L; Kupčinskas L
Medicina (Kaunas); 2016; 52(6):325-330. PubMed ID: 27932194
[TBL] [Abstract][Full Text] [Related]
37. Association between IL-10 rs3024505 and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.
Liu M; Yuan W; Park S
Cytokine; 2022 Jan; 149():155721. PubMed ID: 34628128
[TBL] [Abstract][Full Text] [Related]
38. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
39. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India.
Ahirwar DK; Kesarwani P; Singh R; Ghoshal UC; Mittal RD
J Gastrointest Cancer; 2012 Jun; 43(2):196-204. PubMed ID: 21249467
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population.
Li CS; Zhang Q; Lee KJ; Cho SW; Lee KM; Hahm KB; Choi SC; Yun KJ; Chung HT; Chae SC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1692-6. PubMed ID: 19686419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
